Diagnosis of bacterial and fungal pathogens using culture-independent molecular testing
Join us Monday, November 16, to explore the advantages and applications of direct molecular testing
3 Nov 2020Conventional culture methods for the diagnosis of bacterial and fungal infections are often limited by a long time of culturing or the occurrence of negative results due to the administration of antibiotics or fastidious growth requirements. As an accepted alternative, culture-independent approaches are widely used.
In this webinar, Dr. Michael Lustig, COO at Molzym GmbH & Co. KG, will share his vast experience of direct molecular testing and present a wide overview of available solutions and their applications. The factors that favor direct testing will be outlined and the diagnostic value of broad-range 16S/18S rRNA gene PCR and how the results impact the antimicrobial therapy selection will also be discussed.
Register nowThis webinar will cover the following:
- Limitations of conventional culture methods
- Advantages, disadvantages and applications of specific PCR, multiplex PCR and universal broad-range PCR assays
- Factors influencing the performance of direct molecular testing
- Requirements that favor direct testing
- Diagnostic value and clinical impact of broad-range 16S/18S rRNA gene PCR and sequencing
Who should attend?
- Laboratory directors, laboratory managers, quality managers
- Clinical, hospital, and laboratory stakeholders
- Clinicians, medical laboratory scientists and technicians
The live webinar takes place on Monday, November 16, at:
- 15:00 GMT
- 16:00 CET
- 07:00 PST
- 10:00 EST
SelectScience runs 10+ webinars a month across various scientific topics, discover more of our upcoming webinars>>